Infectious diseases: Two-hit antibody tackles bacteria

Nature Reviews Drug Discovery

Volumn 14, Issue 1, 2014, Pages 15-

  Kingwell, Katie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BISPECIFIC ANTIBODY; CIPROFLOXACIN; EPITOPE; MEDI 3902; MEROPENEM; PCRV PROTEIN; PSL PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TOBRAMYCIN; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; MONOCLONAL ANTIBODY;

ADJUVANT THERAPY; BACTERIAL CLEARANCE; BACTERIUM ADHERENCE; DRUG POTENTIATION; DRUG TARGETING; NONHUMAN; NOTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; PSEUDOMONAS PNEUMONIA; ANIMAL; HUMAN; IMMUNOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, BISPECIFIC; ANTIBODIES, MONOCLONAL; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84925962821     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd4525     Document Type: Note

References (2)

1. ORIGINAL RESEARCH PAPER DiGiandomenico, A. et al. A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Sci. Transl. Med. 6, 262ra155 (2014)
2. FURTHER READING Garber, K. Bispecific antibodies rise again. Nature Rev. Drug Discov. 13, 799-801 (2014)